PGNY · NASDAQ
Progyny, Inc.
$28.30 -0.67 (-2.31%)
Company overview
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Exchange
- NASDAQ
- Market cap
- $2.2B
- Employees
- 675
- Headquarters
- New York City, NY
- Website
- progyny.com
- CEO
- David J. Schlanger
- Listed
- October 25, 2019
- P/E
- 34.94
- Dividend yield
- 0.00%
Company financials
- Revenue
- $1.3B
- Gross profit
- $312M
- Operating income
- $96.5M
- EBITDA
- $108M
- Net income
- $67.7M
- EPS
- $0.81
- Total assets
- $698M
- Total debt
- $27.3M
- Gross margin
- 24.11%
- Net margin
- 5.23%
- Earnings yield
- 2.86%
No geographic segmentation.
Showing FY 2025
PGNY
1D
NASDAQ
O29.06H29.11L28.80C28.97-0.15 (-0.52%)Vol565.86K